3 results match your criteria: "the 59th Clinical Research Squadron[Affiliation]"
J Vasc Surg
April 2011
Wilford Hall USAF Medical Center, the 59th Clinical Research Squadron, Lackland Air Force Base, Tex., USA.
Background: In order to advance beyond basic statistical limb salvage to improved functional or quality limb salvage, a better understanding of the ischemic threshold of the limb is required. To date, models of extremity ischemia and reperfusion involve small animals and few include survival with physiologic measures of nerve and muscle recovery. In addition, the effect of hemorrhagic shock on the ischemic threshold of the extremity is unknown.
View Article and Find Full Text PDFJ Vasc Surg
January 2011
San Antonio Military Medicine Center Consortium, Wilford Hall United States Air Force Medical Center, the 59th Clinical Research Squadron, and Genesis Concepts & Consultants (under USAF Contract No: FA7014-09-D-0008), Lackland Air Force Base, San Antonio, TX, USA.
Background: Despite advances in revascularization following extremity vascular injury, the relationship between time to restoration of flow and functional limb salvage is unknown. The objectives of this study are to describe a large animal survival model of hind limb ischemia/reperfusion and define neuromuscular recovery following increasing ischemic periods.
Methods: Sus scrofa swine (N = 38; weight, 87 ± 6.
J Trauma
July 2010
Department of Surgery, San Antonio Military Medicine Center Consortium, Wilford Hall USAF Medical Center and the 59th Clinical Research Squadron, Lackland Air Force Base, Texas 78236, USA.
Background: Extremity ischemia/reperfusion has been studied mostly in small-animal models with limited characterization of neuromuscular or functional outcome. The objective of this experiment was to report a large-animal survival model of extremity ischemia/reperfusion using circulating, electromyographic (EMG), gate, and histologic measures of injury and limb recovery.
Methods: Sus scrofa swine (n = 6; mean, 83 kg) were randomized to iliac artery occlusion for 0 (control), 1 (1 HR), 3 (3 HR), or 6 (6 HR) hours.